Jan‐Michel Heger

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma

Jan‐Michel Heger, Laman Mammadova, Julia Mattlener et al. · Journal of Clinical Oncology · 2024 · 40 citations

Medicine, Molecular Medicine, Oncology +17

Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy

Jiaqi Fan, Anne Adams, Noëlle Sieg et al. · Radiotherapy and Oncology · 2023 · 39 citations

Medicine, Oncology, Radiation Oncology +16

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

Jan‐Michel Heger, Julia Mattlener, Jessica Schneider et al. · Blood · 2023 · 39 citations

Medicine, Oncology, Pathology +16

Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient

Philipp Gödel, Noëlle Sieg, Jan‐Michel Heger et al. · HemaSphere · 2021 · 22 citations · Full text

Medicine, Hematology, Oncology +16